Our previous studies have demonstrated that SFN can activate the estrogen receptor (ER) gene and suppress human telomerase reverse transcriptase (hTERT) in ER-negative [ER(-)] BC cells via epigenetic processes [20,21]. Here, ESR1 is linked to breast cancer.